65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03232203 (ClinicalTrials.gov)	April 12, 2018	25/7/2017	Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)	Evaluation of Referring HCPs' and Parents'/Carers' Understanding of Specific Risks Associated With S ...	Severe Combined Immunodeficiency Due to ADA Deficiency	Drug: STRIMVELIS	Orchard Therapeutics	NULL	Completed	18 Years	N/A	All	16		Italy
2	EUCTR2017-001731-39-IT (EUCTR)	12/10/2017	02/07/2020	Retroviral insertion site methodology study	Methodology study to investigate the utility of retroviral insertion site analysis in samples from s ...	Adenosine deaminase (ADA) deficiency severe combined immunodeficiency MedDRA version: 20.1;Level: LL ...	Trade Name: Strimvelis Product Name: Strimvelis Product Code: [NA]	Orchard Therapeutics (Europe) Ltd	NULL	Not Recruiting			Female: yes Male: yes	15	Phase 4	Turkey;Switzerland;Italy
3	NCT03478670 (ClinicalTrials.gov)	March 31, 2017	23/3/2018	StrimvelisRegistry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodefici ...	Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated With S ...	Immunologic Deficiency Syndromes	Genetic: Strimvelis	Orchard Therapeutics	NULL	Enrolling by invitation	N/A	N/A	All	50		Italy

First Previous1Next Last